Cargando…
Predicted savings to the UK National Health Service from switching to generic antiretrovirals, 2014–2018
INTRODUCTION: In other disease areas, generic drugs are normally used after patent expiry. Patents on zidovudine, lamivudine, nevirapine and efavirenz have already expired. Patents will expire for abacavir in late 2014, lopinavir/r in 2016, and tenofovir, darunavir and atazanavir in 2017. However, p...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International AIDS Society
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224875/ https://www.ncbi.nlm.nih.gov/pubmed/25394006 http://dx.doi.org/10.7448/IAS.17.4.19497 |